兰西哈三联制药

Lanxi Ha Sanlian Pharmaceutical Co., Ltd. is a key manufacturing subsidiary of Harbin Sanlian Pharmaceutical Co., Ltd., a publicly traded company on the Shenzhen Stock Exchange. Based in Lanxi County, Heilongjiang, the company specializes in the production of chemical APIs and diverse pharmaceutical formulations, including large and small volume injections and solid dosages. Its core product offerings target therapeutic areas such as cardiovascular diseases, neurology, and anesthesiology. The facility operates under strict GMP standards and serves as a primary production hub for the parent group's commercial portfolio. In addition to internal production, the company provides contract manufacturing services for various domestic pharmaceutical partners. The entity is integral to Harbin Sanlian's strategy of vertical integration within the Chinese healthcare market.